CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

Clinical trial NCT03504488 · COMPLETED

Trial details

NCT number: NCT03504488
Sponsor: BioAtla, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Triple Negative Breast Cancer Melanoma Head and Neck Cancer

Start date: 2018-06-27
Primary completion: 2024-12-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.